Beruflich Dokumente
Kultur Dokumente
A
C
BIOCON LTD
Gemba:
QUALITY ASSURANCE
Preliminary Objectives
To Reduce the Approval time for Vials ( IP
stage) to 3 days from sterility release date
Team Name:B1FQA
Members: (R-L)Nilang Mehta, Ajay Puranik, Prabhakar M D,
Uma K S.
No Of Days
1
0
1
11 13 15 17 19 21 23 25 27 29 31 33 35
9
8
Concerns /
Problems
needing
attention :
No Of Batches
7
6
5
5
4
3
3
2
1
1
1
0
1.Large
variations in
Batch
Approval days.
2.Average = 4.6
Days
3.Range 8 Days
No Of Batches
20
18
16
14
12
10
8
6
4
2
0
19
6
3
1 day
2 day
3 day
Approval Time in Days
4 day
Before Kaizen
Target
After
Kaizen
%
Improve
d
36
100 %
83%
40%
4.6 Days
3 Days
1.9 Days
59%
5
4
No Of Days
3
2
1
0
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35
One time
Financial
Benefit
Annual
Benefit
(Money Value)
Biocon- Gemba
frequency of updation
Year
2013
Location
Gebma
QA
Owner
Good
3 days
Uma
5
5
4
4
3
3
2
2
1
1
0
Mr.13
Mar-13
Apr.13
Apr-13
Mai.13
May-13
Jun.13
Jun-13
Jul.13
Jul-13
Aug.13
Aug-13
Sep.13
Sep-13
Okt.13
Nov.13
Oct-13
Dez.13
Nov-13
Jn.14
Dec-13
Feb.14
Jan-14
Mr.14
Feb-14
Apr.14
Mar-14
Apr-14